Eti Meiri

Eti has over 18 years of experience in various leadership roles, most recently as VP of Research & Development at Rosetta Genomics. There she led the development of novel platform technologies for oncological and heart disease diagnostics, resulting in the launch of five molecular tests which have been used in the treatment of cancer patients. Eti’s experience also includes guiding and supervising Rosetta's clinical CAP-certified laboratory in Philadelphia. During her career Eti has authored 30 publications in scientific journals and is an inventor on numerus patents or patent applications in the fields of qPCR, microarrays, and oncology biomarkers. She received a PhD from the Weizmann Institute of Science and an MSc from the Hebrew University of Jerusalem.